[
    [
        {
            "time": "",
            "original_text": "南微医学（688029）：内镜诊疗领域领军者，三大技术平台奠定高成长【西南医药朱国广陈铁林团队】",
            "features": {
                "keywords": [
                    "南微医学",
                    "内镜诊疗",
                    "领军者",
                    "三大技术平台",
                    "高成长",
                    "西南医药",
                    "朱国广",
                    "陈铁林"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "南微医学（688029）：内镜诊疗领域领军者，三大技术平台奠定高成长【西南医药朱国广陈铁林团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]